Triomune is a co-formulated medicine with a combination of three antiviral medicines. The tablets contain lamivudine 150mg, stavudine 30mg, and nevirapine 200mg anti-viral and are generally effective for the management of HIV infection. Cipla is the manufacturer of the medicine